...
首页> 外文期刊>Kidney International Reports >Glomerular C3 Deposition Is an Independent Risk Factor for Allograft Failure in Kidney Transplant Recipients With Transplant Glomerulopathy
【24h】

Glomerular C3 Deposition Is an Independent Risk Factor for Allograft Failure in Kidney Transplant Recipients With Transplant Glomerulopathy

机译:肾小球C3沉积是肾移植受者的同种异体移植失败的独立危险因素,具有移植肾小球病

获取原文

摘要

IntroductionTransplant glomerulopathy (TG) becomes increasingly prevalent in kidney transplant recipients over time, and it is strongly associated with allograft failure. To date, our prognostic biomarkers and understanding of the processes of immunologic injury in TG are limited.MethodsThis is a retrospective cohort analysis of kidney transplant recipients with TG (double contours of the glomerular basement membrane as defined by the chronic glomerulopathy score). Glomerular deposition of the complement protein C3 was determined, and its association with allograft survival was analyzed by Cox regression analysis.ResultsOf the 111 patients with TG, 72 (65%) had allograft failure, with a median follow-up time of 3 years from biopsy diagnosis of TG. C3-positive compared to C3-negative patients did not differ with respect to cause of end-stage renal disease, induction or maintenance immunosuppression, or sensitization. A greater proportion of patients with glomerular C3 deposition developed allograft failure compared to those with no C3 deposition (78% vs. 55%,P?= 0.01). C3 deposition was independently associated with allograft failure in multivariate analyses (adjusted hazard ratio [HR]?= 1.38, 95% confidence interval [CI]?= 1.13?1.69,P?= 0.002). There was no association between C4d or C1q deposition and allograft failure. Chronicity score was also associated with allograft failure in multivariate analysis (adjusted HR 1.26, 95% CI 1.12-1.41,P= 0.0001).ConclusionIn this cohort of patients with TG, glomerular C3 deposition was independently associated with a higher risk of allograft failure. These findings identify glomerular C3 as a novel prognostic indicator in patients with TG.
机译:随着时间的推移,肾移植受者的引言转移肾小球疗法(TG)变得越来越普遍,并且与同种异体移植失败有关。迄今为止,我们的预后生物标志物和对TG免疫损伤过程的理解是有限的。方法是肾移植受者的回顾性队列分析,具有Tg(由慢性肾小球病评分所定义的肾小球基底膜的双轮廓)。测定补体蛋白C3的肾小球沉积,通过COX回归分析分析其与同种异体移植存活的关联。结果,111例TG患者,72例(65%)有同种异体移植失效,从中中间后续时间为3年TG的活检诊断。与C3阴性患者相比,C3阳性与终末期肾病,诱导或维持免疫抑制或敏化的原因没有不同。与没有C3沉积的人相比,更大比例的肾小球C3沉积患者发育了同种异体移植失败(78%对55%,P≥0.01)。 C3沉积与多变量分析中的同种异体移植衰竭独立相关(调节的危险比[HR] = 1.38,95%置信区间[CI]?= 1.13?1.69,P?= 0.002)。 C4D或C1Q沉积与同种异体移植失败之间没有关联。慢性分数也与多元分析中的同种异体移植失败相关(调整后的HR 1.26,95%CI 1.12-1.41,P = 0.0001)。该患者的TG患者,肾小球C3沉积的群体与同种异体移植失败的风险较高。这些发现将肾小球C3鉴定为TG患者的新型预后指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号